Reference:
1. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015). Lancet 386 (9995):743-800. doi: 710.1016/S0140-6736(1015)60692-60694.
2. Vaduganathan M, Patel RB, Michel A, Shah SJ, Senni M, Gheorghiade M, et al (2017) Mode of Death in Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol 69 (5):556-569. doi: 510.1016/j.jacc.2016.1010.1078.
3. van der Meer P, Gaggin HK, Dec GW (2019) ACC/AHA Versus ESC Guidelines on Heart Failure: JACC Guideline Comparison. J Am Coll Cardiol 73 (21):2756-2768. doi: 2710.1016/j.jacc.2019.2703.2478.
4. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (21):2140-2150. doi: 2110.1056/NEJMoa032423.
5. Barra S, Providência R, Tang A, Heck P, Virdee M, Agarwal S (2015) Importance of Implantable Cardioverter-Defibrillator Back-Up in Cardiac Resynchronization Therapy Recipients: A Systematic Review and Meta-Analysis. J Am Heart Assoc 4 (11):e002539. doi: 002510.001161/JAHA.002115.002539.
6. Döring M, Ebert M, Dagres N, Müssigbrodt A, Bode K, Knopp H, et al (2018) Cardiac resynchronization therapy in the ageing population - With or without an implantable defibrillator? Int J Cardiol 263:48-53. (doi):10.1016/j.ijcard.2018.1003.1087.
7. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37 (27):2129-2200. doi: 2110.1093/eurheartj/ehw2128.
8. Munir MB, Althouse AD, Rijal S, Shah MB, Abu Daya H, Adelstein E, et al (2016) Clinical Characteristics and Outcomes of Older Cardiac Resynchronization Therapy Recipients Using a Pacemaker versus a Defibrillator. J Cardiovasc Electrophysiol 27 (6):730-734. doi: 710.1111/jce.12951.
9. Witt CT, Kronborg MB, Nohr EA, Mortensen PT, Gerdes C, Jensen HK, et al (2016) Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy. Europace 18 (3):413-419. doi: 410.1093/europace/euv1212.
10. Barra S, Boveda S, Providência R, Sadoul N, Duehmke R, Reitan C, et al (2017) Adding Defibrillation Therapy to Cardiac Resynchronization on the Basis of the Myocardial Substrate. J Am Coll Cardiol 69 (13):1669-1678. doi: 1610.1016/j.jacc.2017.1601.1042.
11. Barra S, Providência R, Duehmke R, Boveda S, Marijon E, Reitan C, et al (2017) Sex-specific outcomes with addition of defibrillation to resynchronisation therapy in patients with heart failure. Heart 103 (10):753-760. doi: 710.1136/heartjnl-2016-310677.
12. Laish-Farkash A, Bruoha S, Katz A, Goldenberg I, Suleiman M, Michowitz Y, et al (2017) Morbidity and mortality with cardiac resynchronization therapy with pacing vs. with defibrillation in octogenarian patients in a real-world setting. Europace 19 (8):1357-1363. doi: 1310.1093/europace/euw1238.
13. Martens P, Verbrugge FH, Nijst P, Dupont M, Nuyens D, Herendael HV, et al (2017) Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator. Heart 103 (24):1977-1984. doi: 1910.1136/heartjnl-2017-311423.
14. Yokoshiki H, Shimizu A, Mitsuhashi T, Furushima H, Sekiguchi Y, Manaka T, et al (2017) Survival and Heart Failure Hospitalization in Patients With Cardiac Resynchronization Therapy With or Without a Defibrillator for Primary Prevention in Japan - Analysis of the Japan Cardiac Device Treatment Registry Database. Circ J 81 (12):1798-1806. doi: 1710.1253/circj.CJ-1717-0234.
15. Leyva F, Qiu T, Zegard A, McNulty D, Evison F, Ray D, et al (2019) Sex-Specific Differences in Survival and Heart Failure Hospitalization After Cardiac Resynchronization Therapy With or Without Defibrillation. J Am Heart Assoc 8 (22):e013485. doi: 013410.011161/JAHA.013119.013485.
16. Leyva F, Zegard A, Okafor O, de Bono J, McNulty D, Ahmed A, et al (2019) Survival after cardiac resynchronization therapy: results from 50 084 implantations. Europace 21 (5):754-762. doi: 710.1093/europace/euy1267.
17. Saba S, McLaughlin T, He M, Althouse A, Mulukutla S, Hernandez I (2019) Cardiac resynchronization therapy using pacemakers vs defibrillators in patients with nonischemic cardiomyopathy: The United States experience from 2007 to 2014. Heart Rhythm 16 (7):1065-1071. doi: 1010.1016/j.hrthm.2019.1004.1028.
18. Wang Y, Sharbaugh MS, Althouse AD, Mulukutla S, Saba S (2019) Cardiac resynchronization therapy pacemakers versus defibrillators in older non-ischemic cardiomyopathy patients. Indian Pacing Electrophysiol J 19 (1):4-6. doi: 10.1016/j.ipej.2018.1008.1002.
19. Liang Y, Wang J, Yu Z, Zhang M, Pan L, Nie Y, et al (2020) Comparison between cardiac resynchronization therapy with and without defibrillator on long-term mortality: A propensity score matched analysis. J Cardiol 75 (4):432-438. doi: 410.1016/j.jjcc.2019.1008.1018.
20. Marijon E, Leclercq C, Narayanan K, Boveda S, Klug D, Lacaze-Gadonneix J, et al (2015) Causes-of-death analysis of patients with cardiac resynchronization therapy: An analysis of the CeRtiTuDe cohort study. European Heart Journal 36 (41):2767-2776. doi: 10.1093/eurheartj/ehv455
21. Pappone C, Vicedomini G, Augello G, Mazzone P, Nardi S, Rosanio S (2003) Combining electrical therapies for advanced heart failure: the Milan experience with biventricular pacing-defibrillation backup combination for primary prevention of sudden cardiac death. Am J Cardiol 91 (9A):74F-80F. doi: 10.1016/s0002-9149(1002)03341-03346.
22. Kutyifa V, Geller L, Bogyi P, Zima E, Aktas MK, Ozcan EE, et al (2014) Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience. Eur J Heart Fail 16 (12):1323-1330. doi: 1310.1002/ejhf.1185.
23. Gillebert C, Marynissen T, Janssen R, Droogne W, Voros G, Garweg C, et al (2014) How to choose between a pacemaker or defibrillator for resynchronization therapy? Acta Cardiol 69 (5):483-489. doi: 410.1080/ac.1069.1085.3044874.
24. Gold MR, Daubert JC, Abraham WT, Hassager C, Dinerman JL, Hudnall JH, et al (2013) Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE). Circ Arrhythm Electrophysiol 6 (6):1163-1168. doi: 1110.1161/CIRCEP.1113.000570.
25. Reitan C, Chaudhry U, Bakos Z, Brandt J, Wang L, Platonov PG, et al (2015) Long-term results of cardiac resynchronization therapy: A comparison between crt-pacemakers versus primary prophylactic CRT-defibrillators. PACE - Pacing and Clinical Electrophysiology 38 (6):758-767. doi:10.1111/pace.12631
26. Killu AM, Wu JH, Friedman PA, Shen WK, Webster TL, Brooke KL, et al (2013) Outcomes of cardiac resynchronization therapy in the elderly. Pacing Clin Electrophysiol 36 (6):664-672. doi: 610.1111/pace.12048.
27. Morani G, Gasparini M, Zanon F, Casali E, Spotti A, Reggiani A, et al (2013) Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry. Europace 15 (9):1273-1279. doi: 1210.1093/europace/eut1032.
28. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (15):1539-1549. doi: 1510.1056/NEJMoa050496.
29. Lindvall C, Chatterjee NA, Chang Y, Chernack B, Jackson VA, Singh JP, et al (2016) National Trends in the Use of Cardiac Resynchronization Therapy With or Without Implantable Cardioverter-Defibrillator. Circulation 133 (3):273-281. doi: 210.1161/CIRCULATIONAHA.1115.018830.
30. Shen L, Jhund PS, Petrie MC, Claggett BL, Barlera S, Cleland JGF, et al (2017) Declining Risk of Sudden Death in Heart Failure. N Engl J Med 377 (1):41-51. doi: 10.1056/NEJMoa1609758.
31. Ruwald MH, Solomon SD, Foster E, Kutyifa V, Ruwald AC, Sherazi S, et al (2014) Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial. Circulation 130 (25):2278-2286. doi: 2210.1161/CIRCULATIONAHA.2114.011283.
32. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, et al (2008) Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 51 (14):1357-1365. doi: 1310.1016/j.jacc.2007.1309.1073.
33. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, et al (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359 (10):1009-1017. doi: 1010.1056/NEJMoa071098.
34. Ziaeian B, Zhang Y, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, et al (2014) Clinical effectiveness of CRT and ICD therapy in heart failure patients by racial/ethnic classification: insights from the IMPROVE HF registry. J Am Coll Cardiol 64 (8):797-807. doi: 710.1016/j.jacc.2014.1005.1060.
35. Kramer DB, Normand ST, Volya R, Hatfield LA (2018) Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator. Circ Cardiovasc Qual Outcomes 11 (12):e004763. doi: 004710.001161/CIRCOUTCOMES.004118.004763.
36. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia (1997). Circulation 95 (4):777. doi: 710.1161/1101.cir.1195.1164.1777.
37. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G (1999) A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 341 (25):1882-1890. doi: 1810.1056/NEJM199912163412503.
38. Køber L, Thune JJ, Nielsen JC, Haarbo J, Videbæk L, Korup E, et al (2016) Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. N Engl J Med 375 (13):1221-1230. doi: 1210.1056/NEJMoa1608029.
39. Duncan A, Wait D, Gibson D, Daubert JC (2003) Left ventricular remodelling and haemodynamic effects of multisite biventricular pacing in patients with left ventricular systolic dysfunction and activation disturbances in sinus rhythm: sub-study of the MUSTIC (Multisite Stimulationin Cardiomyopathies) trial. Eur Heart J 24 (5):430-441. doi: 410.1016/s0195-1668x(1002)00475-x.
40. Sutton MG, Plappert T, Hilpisch KE, Abraham WT, Hayes DL, Chinchoy E (2006) Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Circulation 113 (2):266-272. doi: 210.1161/CIRCULATIONAHA.1104.520817.
41. Barsheshet A, Wang PJ, Moss AJ, Solomon SD, Al-Ahmad A, McNitt S, et al (2011) Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy). J Am Coll Cardiol 57 (24):2416-2423. doi: 2410.1016/j.jacc.2010.2412.2041.
42. Barra S, Providência R, Duehmke R, Boveda S, Begley D, Grace A, et al (2018) Cause-of-death analysis in patients with cardiac resynchronization therapy with or without a defibrillator: a systematic review and proportional meta-analysis. Europace 20 (3):481-491. doi: 410.1093/europace/eux1094.
43. Barra S, Providência R, Boveda S, Duehmke R, Narayanan K, Chow AW, et al (2018) Device complications with addition of defibrillation to cardiac resynchronisation therapy for primary prevention. Heart 104 (18):1529-1535. doi: 1510.1136/heartjnl-2017-312546.